Tempest Therapeutics, Inc. — Director's Dealing 2021

Sep 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tempest Therapeutics, Inc. (TPST)
CIK: 0001544227
Period of Report: 2021-09-21

Reporting Person: RAAB MICHAEL (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-21	Stock Option (Right to Buy)	$15.15	A	6635	Acquired	2031-09-20	Common Stock (6635)	Direct

Footnotes

F1: Vests over three (3) years, with one-third (1/3) of the award vesting on July 1, 2022 and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.